BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38715081)

  • 1. The haemagglutinin-neuraminidase protein of velogenic Newcastle disease virus enhances viral infection through NF-κB-mediated programmed cell death.
    Lu X; Zhan T; Zhou Q; Yang W; Liu K; Chen Y; Gao R; Hu J; Gu M; Hu S; Jiao XA; Wang X; Liu X; Liu X
    Vet Res; 2024 May; 55(1):58. PubMed ID: 38715081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Full-length genome analysis of two genotype III velogenic Newcastle diseases virus strains reveals their close relationship with vaccine Mukteswar].
    Qiu X; Sun Q; Yao C; Dong L; Wu Y; Hu S; Liu X
    Wei Sheng Wu Xue Bao; 2009 Mar; 49(3):302-8. PubMed ID: 19623952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular vimentin regulates the infectivity of Newcastle disease virus through targeting of the HN protein.
    Lu X; Liu K; Chen Y; Gao R; Hu Z; Hu J; Gu M; Hu S; Ding C; Jiao X; Wang X; Liu X; Liu X
    Vet Res; 2023 Oct; 54(1):92. PubMed ID: 37848995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo.
    Lu X; Zhan T; Liu K; Chen Y; Hu Z; Hu J; Gu M; Hu S; Wang X; Liu X; Liu X
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.
    Liu J; Zhu J; Xu H; Li J; Hu Z; Hu S; And XW; Liu X
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28809802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and mechanistic study of key sites of the hemagglutinin-neuraminidase protein related to the virulence of Newcastle disease virus.
    Yan C; Liu H; Jia Y; Prince-Theodore DW; Yang M; Addoma Adam FE; Ren J; Cao X; Wang X; Xiao S; Zhang S; Yang Z
    Poult Sci; 2020 Jul; 99(7):3374-3384. PubMed ID: 32616231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle disease virus fusion and haemagglutinin-neuraminidase proteins contribute to its macrophage host range.
    Cornax I; Diel DG; Rue CA; Estevez C; Yu Q; Miller PJ; Afonso CL
    J Gen Virol; 2013 Jun; 94(Pt 6):1189-1194. PubMed ID: 23426356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino Acid Mutations in Hemagglutinin-Neuraminidase Enhance the Virulence and Pathogenicity of the Genotype III Newcastle Disease Vaccine Strain After Intravenous Inoculation.
    Lu X; Liu X; Song Q; Wang X; Hu S; Liu X
    Front Vet Sci; 2022; 9():890657. PubMed ID: 35711809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein.
    Hu S; Wang T; Liu Y; Meng C; Wang X; Wu Y; Liu X
    Vet Microbiol; 2010 Jan; 140(1-2):92-7. PubMed ID: 19729254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of Newcastle disease virus with derivated hemagglutinin-neuraminidase gene of mesogenic strain].
    Wang Y; Ge J; Ding Y; Xie X; Bu Z
    Wei Sheng Wu Xue Bao; 2008 May; 48(5):638-43. PubMed ID: 18652296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the HN gene C-terminal extensions on the Newcastle disease virus virulence.
    Zhao W; Zhang Z; Zsak L; Yu Q
    Virus Genes; 2013 Dec; 47(3):498-504. PubMed ID: 24037042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone.
    Estevez C; King D; Seal B; Yu Q
    Virus Res; 2007 Nov; 129(2):182-90. PubMed ID: 17719672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid substitution in the haemagglutinin-neuraminidase protein of Newcastle disease virus results in increased fusion promotion and decreased neuraminidase activities without changes in virus pathotype.
    Estevez C; King DJ; Luo M; Yu Q
    J Gen Virol; 2011 Mar; 92(Pt 3):544-51. PubMed ID: 21123551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.
    Huang Z; Panda A; Elankumaran S; Govindarajan D; Rockemann DD; Samal SK
    J Virol; 2004 Apr; 78(8):4176-84. PubMed ID: 15047833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicity.
    Khattar SK; Yan Y; Panda A; Collins PL; Samal SK
    J Virol; 2009 Aug; 83(15):7779-82. PubMed ID: 19474107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new amino acid mutation in the HN protein of NDV involved in pathogenicity.
    Chen X; Jia Y; Wei N; Ye C; Hao H; Xiao S; Wang X; Liu H; Yang Z
    Vet Res; 2021 Dec; 52(1):147. PubMed ID: 34930432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutinin-Neuraminidase and fusion genes are determinants of NDV thermostability.
    Liu T; Song Y; Yang Y; Bu Y; Cheng J; Zhang G; Xue J
    Vet Microbiol; 2019 Jan; 228():53-60. PubMed ID: 30593380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.
    Kumar S; Nayak B; Collins PL; Samal SK
    J Virol; 2011 Jul; 85(13):6521-34. PubMed ID: 21525340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
    Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
    Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.